Advertisement
Screener

Tempest Therapeutics, Inc. (TPST) Capital Expenditures Incurred but Not yet Paid

1.4 / 5 stars · 18/64 Roast Me

Tempest Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid

Tempest Therapeutics, Inc. (TPST) reported Capital Expenditures Incurred but Not yet Paid of $152.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-03.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2019-04-01

  • Tempest Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2018-03-31 was $152.00K, a 484.62% increase year-over-year.
  • Tempest Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2017-03-31 was $26.00K.
  • Tempest Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2016-03-31 was $0.00.
  • Tempest Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2017 was $524.00K.
Period endCapital Expenditures Incurred but Not yet Paid 3 monthCapital Expenditures Incurred but Not yet Paid 3 month as first filedCapital Expenditures Incurred but Not yet Paid 12 month
2018-03-31$152.00K
10-Q · filed 2018-05-03
2017-12-31$524.00K
10-K · filed 2019-04-01
2017-03-31$26.00K
10-Q · filed 2018-05-03
$0.00
10-Q · filed 2017-05-09
2016-03-31$0.00
10-Q · filed 2017-05-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
BIOVIE INC. (BIVI)United States$0.012B
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B